Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 01877 JUNSHI BIO > Detailed Quotes

01877 JUNSHI BIO

23.250
-1.150-4.71%
Closed 09/23 16:08 CCT
High
24.950
Open
24.950
Turnover
33.55M
Low
23.050
Pre Close
24.400
Volume
1.43M
Market Cap
21.22B
P/E(TTM)
Loss
52wk High
68.650
Shares
912.60M
P/E(Static)
Loss
52wk Low
23.050
Float Cap
5.10B
Bid/Ask %
16.18%
Historical High
97.150
Shs Float
219.30M
Volume Ratio
1.64
Historical Low
20.000
Dividend TTM
--
Div Yield TTM
--
P/B
2.54
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.65%
Amplitude
7.79%
Avg Price
23.445
Lot Size
200
Float Cap
5.10B
Bid/Ask %
16.18%
Historical High
97.150
Shs Float
219.30M
Volume Ratio
1.64
Historical Low
20.000
Dividend TTM
--
P/B
2.54
Dividend LFY
--
Turnover Ratio
0.65%
Amplitude
7.79%
Avg Price
23.445
Lot Size
200
Price Forecast

No Data

News

Comment

Company Overview More
Shanghai Junshi Biotechnology Co., Ltd. is a Chinese company mainly engaged in innovation-driven biopharmaceutical business. The company's main business is innovative drug discovery, clinical research and development. The company's main products include Teripumab injection, Etiumab injection, Adamumab injection and other drugs used in the treatment of malignant tumors, autoimmune diseases, chronic metabolic diseases, nervous system diseases and infectious diseases. The company is also engaged in clinical research and development of recombinant humanized anti-PCSK9 monoclonal antibody injection and other drugs. The company mainly provides products for domestic and foreign markets.
CEO: Jun Xiong
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...